Weight loss of over 100 lbs in a patient of Prader-Willi syndrome treated with glucagon-like peptide-1 (GLP-1) agonists
Ease of use across the entire platform Ease of use across the entire platform, communication is timely and extremely helpful
doi:10.1111/dom.13343 Malekshahi Moghadam A, Saedisomeolia A, Djalali M, Djazayery A, Pooya S, Sojoudi F
Intermediate phase (weeks 5-8) This is when body composition changes typically become noticeable
FDA Approval vs Compounding vs Research Use In real-world practice, this may be the biggest differentiator: Sermorelin: Previously marketed (Geref), now often encountered via compounding rather than as an FDA-approved commercial product (FDA, 2013)
While not a "magic solution," these injections provide: Enhanced fat filtering through inositol regulation Improved fat metabolism via choline More effective mobilization of fat deposits Is it safe to have B12 injections every month